Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Gallo: FLSC Phase I & II Clinical Trials |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2018-11-09 |
| Study Made Public: | 2020-05-29 |
Title
IHV mAb screening
Description
CAVD 767 is a monoclonal antibody screening study evaluating natural and engineered mAbs from Elite Neutralizers for neutralization activity.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.